SaxoTV

Astra Zeneca and Pfizer: Five things you need to know

193 views
May 13, 2014 astrazeneca, deal, drugs, drugs sector, eurozone, hostile, medical stocks, medicines, merger, patents, peter garnry, pfizer, pharma, pharma space, pharmaceutical sales, pharmaceuticals, pharmacies, saxo tv, shares, shares down, shares or bonds, shares prices, shares up, stock, stock futures, stock market, stock pick, stock picks, stock price, stock prices, stocks, takeover, tax, tax cut, tax policy, taxes, tradingfloor.com, uk, uk economy, uk gdp, uk growth, uk inflation, uk manufacturing, uk recovery, uk unemployment, uk wages, us economy, viagra

As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects of this massive drug firm deal? Here are five things you need to know.:

- The deal is potentially worth around 100 billion dollars.

- American firm Pfizer is accused to only wanting to buy the British company Astra Zeeneca to take advantage of lower UK corporate rates.

- The deal has split political opinion in the UK with opposition parties urging the government to intervene.

- The deal could end up being decided by the European Commission which could overrule the UK government.  

- The Swedish finance minister  warned to take Pfizer’s promises with “a sackful of salt”